Dashboard
Manage Tickers

RNXTRenovoRx, Inc.

Nasdaq www.renovorx.com


$ 1.07 $ 0.06 (5.19 %)    

Thursday, 12-Sep-2024 15:57:39 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 1.1255
$ 1.08 x 100
-- x --
-- - --
$ 0.53 - $ 2.35
30,402
na
27M
$ 1.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-16-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-12-2022 06-30-2022 10-Q
10 05-13-2022 03-31-2022 10-Q
11 03-30-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

exact-sciences-to-rally-around-33-here-are-10-top-analyst-forecasts-for-thursday
Exact Sciences To Rally Around 33%? Here A...
09/12/2024 12:21:35

ascendiant-capital-maintains-buy-on-renovorx-raises-price-target-to-825
Ascendiant Capital Maintains Buy on Renovo...
09/12/2024 10:00:36

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $8 to $8.25.

renovorx-announces-first-patient-enrolled-at-university-of-nebraska-medical-center-for-pivotal-phase-iii-tiger-pac-clinical-trial
RenovoRx Announces First Patient Enrolled ...
08/14/2024 12:35:35

renovorx-publishes-positive-early-stage-data-on-tamp-therapy-for-locally-advanced-pancreatic-cancer
RenovoRx Publishes Positive Early-Stage Da...
07/31/2024 12:41:18

Chemotherapy Delivered Via TAMP With Prior Chemoradiation Shows 27-Month Overall Survival; Ongoing Phase III Trial Evaluates Ta...

renovorx-publishes-treatment-of-locally-advanced-pancreatic-cancer-lapc-using-localized-trans-arterial-micro-perfusion-tamp-of-gemcitabine-combined-analysis-of-rr1-and-rr2--in-the-oncologist
RenovoRx Publishes "Treatment of Locally A...
07/08/2024 12:34:17

university-of-nebraska-medical-center-to-enroll-patients-for-renovorxs-phase-iii-tiger-pac-clinical-trial
University of Nebraska Medical Center To E...
06/26/2024 12:33:58

ascendiant-capital-initiates-coverage-on-renovorx-with-buy-rating-announces-price-target-of-8
Ascendiant Capital Initiates Coverage On R...
06/17/2024 11:00:18

Ascendiant Capital analyst Edward Woo initiates coverage on RenovoRx (NASDAQ:RNXT) with a Buy rating and announces Price Tar...

why-ammo-shares-are-trading-lower-by-over-19-here-are-other-stocks-moving-in-fridays-mid-day-session
Why AMMO Shares Are Trading Lower By Over ...
06/14/2024 18:13:08

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
06/12/2024 20:31:07

renovorx-ceo-updates-shareholder-letter
RenovoRx CEO Updates Shareholder Letter
05/30/2024 12:42:51

Dear Fellow RenovoRx Shareholders,The first quarter of 2024 marked a significant period in our company's evolution, and we ...

renovorx-announces-publication-of-results-of-pre-clinical-studies-support-efficacy-and-drug-delivery-mechanism-potential-of-the-cos-tamp-therapy-platform-to-improve-targeted-cancer-drug-treatment-delivery
RenovoRx Announces Publication Of Results ...
05/21/2024 13:36:16

Data shows that the Trans-Arterial Micro-Perfusion (TAMP) platform increases intra-arterial pressure, improving drug delivery w...

renovorx-regains-nasdaq-compliance
RenovoRx Regains Nasdaq Compliance
04/18/2024 12:35:08

renovorx-executes-definitive-subscription-agreement-with-accredited-investors-for-111m-at-market-private-placement
RenovoRx Executes Definitive Subscription ...
04/08/2024 12:36:43

Cash position now expected to fund current operating plan into 2026Financing provides cash runway to advance the ongoing pivota...

alliance-global-partners-initiates-coverage-on-renovorx-with-buy-rating-announces-price-target-of-4
Alliance Global Partners Initiates Coverag...
02/02/2024 13:04:15

Alliance Global Partners analyst Scott Henry initiates coverage on RenovoRx (NASDAQ:RNXT) with a Buy rating and announces Pr...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/31/2024 17:31:12

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/10/2024 17:31:03

why-longboard-pharmaceuticals-shares-are-trading-higher-by-around-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Longboard Pharmaceuticals Shares Are T...
01/02/2024 18:35:24

Shares of Longboard Pharmaceuticals, Inc.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
01/02/2024 17:31:04

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
01/01/2024 17:30:55

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
12/29/2023 17:31:07

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION